In a notable shift, EVM memory check applications were absent in four of the five recent assembly election states, a stark contrast to previous trends. Only Tamil Nadu saw a handful of such requests, ...

SpaceX has captured the attention of media, investors, and the public for years now — interest propelled by the company’s reusable rocket launches and the rise of its Starlink satellite network, and, ...

An amalgamation of Elon Musk's projects -- not named Tesla -- is now one of the world's largest publicly traded companies. Though the name SpaceX brings to mind the firm's rockets, the much-hyped ...

SpaceX's record-setting IPO is creating a financial windfall for thousands of the company's current and former employees who received stock as part of their compensation. Workers who hold stock in non ...

Before joining Investopedia, David Marino-Nachison was an editor at The Wall Street Journal focused mainly on daily markets and investing news. He also worked on The Journal’s publishing desk; as a ...

SpaceX is launching its initial public offering (IPO) on June 12 at $135 per share. Speculation exists about a potential merger between SpaceX and Tesla, both led by Elon Musk. Tesla's stock has ...

Includes exercise of overallotment options, except for SpaceX; if fully exercised, SpaceX would raise $86 billion. Elon Musk, who pioneered the modern electric vehicle industry, operates the world’s ...

Retail investors are expected to have access to a much larger portion of SpaceX shares than in a typical IPO. Photo Illustration: Rachel Rogers Elon Musk’s SpaceX is preparing to stage the largest ...

Retail investors hoping to cash in on a first-day surge in SpaceX (SPCX) shares may face restrictions from many of the brokerages distributing stock in the company's record-breaking initial public ...

SpaceX is set this week to launch as a publicly traded company, giving ordinary investors a chance to participate in what is expected to be the biggest initial public offering of all time. While ...

Parabilis Medicines’ IPO has lived up to the hype—securing $670 million for the largest listing in the sector’s history. The cancer biotech, formerly known as FogPharma, has offered 33.5 million ...